drugset / Trial / NCT00323635

A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause.

NCT00323635

Phase 4 Terminated 19 enrolled Brigham and Women's Hospital Pfizer · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is being done to compare frequency of urination during the night when women take tolterodine tablets vs. when they take placebo tablets. We will also measure whether between these two treatment conditions there are any differences in women's sleep, mood and performance on cognitive tests.

Timeline

Start
2006-04
Primary completion
2010-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Tolterodine Small molecule 4 mg Oral

Indications